Abstract：
UNASSIGNED: Inappropriate use of short-acting beta2-agonists (SABA) in asthma has been associated with undesired outcomes. This national expert consensus was developed to increase awareness of SABA overuse and provide recommendations on the ways to eliminate SABA overprescription and overreliance in Malaysia.
UNASSIGNED: This expert consensus was developed by searching the PubMed database, using index terms to identify SABA overuse-related burden and recommendations made in asthma guidelines. Consensus recommendations were made via the Delphi method, involving a Malaysian expert committee comprising 13 healthcare professionals (five pulmonologists, four family medicine specialists, two emergency medicine physicians and two pharmacists).
UNASSIGNED: The articles reviewed include randomized controlled trials, systematic reviews, meta-analyses, observational studies, guidelines, and surveys, with abstracts in English and published up until June 2023. Relevant recommendations were also sourced from verified websites of medical organizations and societies.
UNASSIGNED: Eleven consensus statements were developed, each statement achieving a priori agreement level of at least 70%. The statements reflect SABA overreliance in asthma care, as well as recommendations to eliminate SABA overprescription and overreliance in Malaysia. Supporting evidence in the literature as well as expert committee discussions leading to the development of the finalized statements were elaborated.
UNASSIGNED: This national expert consensus discussed the burden of SABA overreliance and made specific recommendations to eliminate SABA overprescription and overreliance in the Malaysian context. This consensus document is anticipated to impart better awareness among Malaysian healthcare providers and contribute to the continuous improvement of asthma care in the country.
UNASSIGNED: This expert consensus was developed by searching the PubMed database, using index terms to identify SABA overuse-related burden and recommendations made in asthma guidelines. Consensus recommendations were made via the Delphi method, involving a Malaysian expert committee comprising 13 healthcare professionals (five pulmonologists, four family medicine specialists, two emergency medicine physicians and two pharmacists).
UNASSIGNED: The articles reviewed include randomized controlled trials, systematic reviews, meta-analyses, observational studies, guidelines, and surveys, with abstracts in English and published up until June 2023. Relevant recommendations were also sourced from verified websites of medical organizations and societies.
UNASSIGNED: Eleven consensus statements were developed, each statement achieving a priori agreement level of at least 70%. The statements reflect SABA overreliance in asthma care, as well as recommendations to eliminate SABA overprescription and overreliance in Malaysia. Supporting evidence in the literature as well as expert committee discussions leading to the development of the finalized statements were elaborated.
UNASSIGNED: This national expert consensus discussed the burden of SABA overreliance and made specific recommendations to eliminate SABA overprescription and overreliance in the Malaysian context. This consensus document is anticipated to impart better awareness among Malaysian healthcare providers and contribute to the continuous improvement of asthma care in the country.
摘要：
■短效β2受体激动剂（SABA）在哮喘中的不当使用与不良结局有关。制定了这项全国专家共识，以传播对SABA过度使用的认识，并就消除SABA在马来西亚哮喘护理中的过度处方和过度依赖的方法提供建议。
■此专家共识是通过搜索PubMed数据库而形成的，使用指数术语确定SABA过度使用相关负担,并在哮喘指南中提出建议.通过德尔菲法提出了共识建议，涉及一个由13名医疗保健专业人员组成的马来西亚专家委员会(五名肺科医生，四位家庭医学专家,两名急诊医师和两名药剂师)。
■审查的文章包括随机对照试验，系统评价,荟萃分析，观察性研究，指导方针,和调查，英文摘要，出版至2023年6月。相关建议也来自经核实的医疗机构和社团网站。
■提出了11项共识声明，每个陈述达到至少70%的先验协议水平。这些陈述反映了SABA在哮喘护理中的过度依赖，以及消除马来西亚SABA过度处方和过度依赖的建议。详细阐述了文献中的支持证据以及专家委员会的讨论，以制定最终的声明。
■这项全国专家共识讨论了SABA过度依赖的负担，并提出了具体建议，以消除马来西亚背景下的SABA过度处方和过度依赖。该共识文件预计将使马来西亚医疗保健提供者更好地认识，并有助于该国哮喘护理的持续改善。
■此专家共识是通过搜索PubMed数据库而形成的，使用指数术语确定SABA过度使用相关负担,并在哮喘指南中提出建议.通过德尔菲法提出了共识建议，涉及一个由13名医疗保健专业人员组成的马来西亚专家委员会(五名肺科医生，四位家庭医学专家,两名急诊医师和两名药剂师)。
■审查的文章包括随机对照试验，系统评价,荟萃分析，观察性研究，指导方针,和调查，英文摘要，出版至2023年6月。相关建议也来自经核实的医疗机构和社团网站。
■提出了11项共识声明，每个陈述达到至少70%的先验协议水平。这些陈述反映了SABA在哮喘护理中的过度依赖，以及消除马来西亚SABA过度处方和过度依赖的建议。详细阐述了文献中的支持证据以及专家委员会的讨论，以制定最终的声明。
■这项全国专家共识讨论了SABA过度依赖的负担，并提出了具体建议，以消除马来西亚背景下的SABA过度处方和过度依赖。该共识文件预计将使马来西亚医疗保健提供者更好地认识，并有助于该国哮喘护理的持续改善。
